Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
×
None is not found in the database.
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
MIGALASTAT HYDROCHLORIDE
(2018)
Small molecule
Alpha-galactosidase A stabiliser
ORAL
Approved
Fabry Disease
MIGALASTAT HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
CLY7M0XD20
Molecule Type:
Small molecule
Molecular Formula:
C6H14ClNO4
Molecular Weight:
199.63
AlogP:
-2.97
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
1.0
Source:
ENCORAFENIB
(2018)
Small molecule
Serine/threonine-protein kinase B-raf inhibitor
ORAL
Approved
Melanoma; Neoplasms
ENCORAFENIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
8L7891MRB6
Molecule Type:
Small molecule
Molecular Formula:
C22H27ClFN7O4S
Molecular Weight:
540.02
AlogP:
3.91
PSA:
140.13
HBD:
3.0
HBA:
#RotB:
9.0
Source:
LUSUTROMBOPAG
(2018)
Small molecule
Thrombopoietin receptor agonist
ORAL
Approved
Hemorrhage; Thrombocytopenia
LUSUTROMBOPAG
×
Maximum Phase:
4
First Approval:
2018
UNII:
6LL5JFU42F
Molecule Type:
Small molecule
Molecular Formula:
C29H32Cl2N2O5S
Molecular Weight:
591.56
AlogP:
8.52
PSA:
97.75
HBD:
2.0
HBA:
#RotB:
13.0
Source:
IVOSIDENIB
(2018)
Small molecule
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
ORAL
Approved
Leukemia, Myeloid, Acute; Neoplasms
IVOSIDENIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
Q2PCN8MAM6
Molecule Type:
Small molecule
Molecular Formula:
C28H22ClF3N6O3
Molecular Weight:
582.97
AlogP:
4.32
PSA:
119.29
HBD:
1.0
HBA:
#RotB:
7.0
Source:
DUVELISIB
(2018)
Small molecule
PI3-kinase p110-delta subunit inhibitor
ORAL
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Follicular; Neoplasms
DUVELISIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
610V23S0JI
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClN6O
Molecular Weight:
416.87
AlogP:
4.48
PSA:
88.49
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SARECYCLINE HYDROCHLORIDE
(2018)
Small molecule
Unknown
ORAL
Approved
Acne Vulgaris; Infections
SARECYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
36718856JR
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClN3O8
Molecular Weight:
523.97
AlogP:
0.11
PSA:
173.86
HBD:
5.0
HBA:
#RotB:
5.0
Source:
PRUCALOPRIDE
(2018)
Small molecule
Serotonin 4 (5-HT4) receptor agonist
Unknown
Approved
Constipation
PRUCALOPRIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
0A09IUW5TP
Molecule Type:
Small molecule
Molecular Formula:
C18H26ClN3O3
Molecular Weight:
367.88
AlogP:
2.09
PSA:
76.82
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TEZACAFTOR
(2018)
Small molecule
Cystic fibrosis transmembrane conductance regulator positive modulator
Unknown
Approved
Cystic Fibrosis
TEZACAFTOR
×
Maximum Phase:
4
First Approval:
2018
UNII:
8RW88Y506K
Molecule Type:
Small molecule
Molecular Formula:
C26H27F3N2O6
Molecular Weight:
520.5
AlogP:
3.4
PSA:
113.18
HBD:
4.0
HBA:
#RotB:
8.0
Source:
GILTERITINIB
(2018)
Small molecule
Tyrosine-protein kinase receptor FLT3 inhibitor
Unknown
Approved
Neoplasms
GILTERITINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
66D92MGC8M
Molecule Type:
Small molecule
Molecular Formula:
C29H44N8O3
Molecular Weight:
552.72
AlogP:
2.7
PSA:
121.11
HBD:
3.0
HBA:
#RotB:
9.0
Source:
FOSTAMATINIB DISODIUM
(2018)
Small molecule
Tyrosine-protein kinase SYK inhibitor
ORAL
Approved
Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
FOSTAMATINIB DISODIUM
×
Maximum Phase:
4
First Approval:
2018
UNII:
86EEZ49YVB
Molecule Type:
Small molecule
Molecular Formula:
C23H36FN6Na2O15P
Molecular Weight:
732.52
AlogP:
3.09
PSA:
186.72
HBD:
4.0
HBA:
#RotB:
10.0
Source:
GLYCOPYRRONIUM TOSYLATE
(2018)
Small molecule
Unknown
TOPICAL
Approved
Arrhythmias, Cardiac; Bronchitis, Chronic; Cerebral Palsy; Hyperhidrosis; Peptic Ulcer; Pulmonary Disease, Chronic Obstructive
GLYCOPYRRONIUM TOSYLATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
1PVF6JLU7B
Molecule Type:
Small molecule
Molecular Formula:
C26H37NO7S
Molecular Weight:
507.65
AlogP:
2.46
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MOXIDECTIN
(2018)
Small molecule
Unknown
ORAL
Approved
Helminthiasis; Onchocerciasis
MOXIDECTIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
NGU5H31YO9
Molecule Type:
Small molecule
Molecular Formula:
C37H53NO8
Molecular Weight:
639.83
AlogP:
5.73
PSA:
116.04
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FOSNETUPITANT CHLORIDE HYDROCHLORIDE
(2018)
Small molecule
Neurokinin 1 receptor antagonist
Unknown
Approved
Nausea; Vomiting
FOSNETUPITANT CHLORIDE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
ZR36MFA9P8
Molecule Type:
Small molecule
Molecular Formula:
C31H37Cl2F6N4O5P
Molecular Weight:
761.53
AlogP:
5.74
PSA:
106.03
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BENZHYDROCODONE HYDROCHLORIDE
(2018)
Small molecule
Opioid receptors; mu/kappa/delta agonist
Unknown
Approved
Acute Pain; Substance-Related Disorders
BENZHYDROCODONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
I894QAU7FJ
Molecule Type:
Small molecule
Molecular Formula:
C25H26ClNO4
Molecular Weight:
439.94
AlogP:
3.72
PSA:
48.0
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TALAZOPARIB
(2018)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
Unknown
Approved
Neoplasms
TALAZOPARIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
9QHX048FRV
Molecule Type:
Small molecule
Molecular Formula:
C19H14F2N6O
Molecular Weight:
380.36
AlogP:
2.63
PSA:
88.49
HBD:
2.0
HBA:
#RotB:
2.0
Source:
SEGESTERONE ACETATE
(2018)
Small molecule
Progesterone receptor agonist
Unknown
Approved
Unknown
SEGESTERONE ACETATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
9AMX4Q13CC
Molecule Type:
Small molecule
Molecular Formula:
C23H30O4
Molecular Weight:
370.49
AlogP:
4.19
PSA:
60.44
HBD:
0.0
HBA:
#RotB:
2.0
Source:
REVEFENACIN
(2018)
Small molecule
Muscarinic acetylcholine receptor M3 antagonist
INHALATION
Approved
Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive
REVEFENACIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
G2AE2VE07O
Molecule Type:
Small molecule
Molecular Formula:
C35H43N5O4
Molecular Weight:
597.76
AlogP:
4.84
PSA:
108.21
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ELAGOLIX
(2018)
Small molecule
Gonadotropin-releasing hormone receptor antagonist
Unknown
Approved
Unknown
ELAGOLIX
×
Maximum Phase:
4
First Approval:
2018
UNII:
5B2546MB5Z
Molecule Type:
Small molecule
Molecular Formula:
C32H30F5N3O5
Molecular Weight:
631.6
AlogP:
5.54
PSA:
102.56
HBD:
2.0
HBA:
#RotB:
12.0
Source:
LOFEXIDINE
(2018)
Small molecule
Unknown
Unknown
Approved
Substance-Related Disorders
LOFEXIDINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
UI82K0T627
Molecule Type:
Small molecule
Molecular Formula:
C11H12Cl2N2O
Molecular Weight:
259.14
AlogP:
2.76
PSA:
33.62
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LAROTRECTINIB
(2018)
Small molecule
Neurotrophic tyrosine kinase receptor inhibitor
Unknown
Approved
Neoplasms
LAROTRECTINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
PF9462I9HX
Molecule Type:
Small molecule
Molecular Formula:
C21H22F2N6O2
Molecular Weight:
428.44
AlogP:
2.95
PSA:
86.0
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BALOXAVIR MARBOXIL
(2018)
Small molecule
Polymerase acidic protein inhibitor
ORAL
Approved
Influenza, Human; Virus Diseases
BALOXAVIR MARBOXIL
×
Maximum Phase:
4
First Approval:
2018
UNII:
505CXM6OHG
Molecule Type:
Small molecule
Molecular Formula:
C27H23F2N3O7S
Molecular Weight:
571.56
AlogP:
3.39
PSA:
99.54
HBD:
0.0
HBA:
#RotB:
4.0
Source:
SODIUM ZIRCONIUM CYCLOSILICATE
(2018)
Small molecule
Potassium chelating agent
ORAL
Approved
Unknown
SODIUM ZIRCONIUM CYCLOSILICATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
D652ZWF066
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELAGOLIX SODIUM
(2018)
Small molecule
Gonadotropin-releasing hormone receptor antagonist
ORAL
Approved
Endometriosis
ELAGOLIX SODIUM
×
Maximum Phase:
4
First Approval:
2018
UNII:
5948VUI423
Molecule Type:
Small molecule
Molecular Formula:
C32H29F5N3NaO5
Molecular Weight:
653.58
AlogP:
5.54
PSA:
102.56
HBD:
2.0
HBA:
#RotB:
12.0
Source:
GLASDEGIB
(2018)
Small molecule
Smoothened homolog antagonist
Unknown
Approved
Neoplasms
GLASDEGIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
K673DMO5H9
Molecule Type:
Small molecule
Molecular Formula:
C21H22N6O
Molecular Weight:
374.45
AlogP:
3.39
PSA:
96.84
HBD:
3.0
HBA:
#RotB:
3.0
Source:
DORAVIRINE
(2018)
Small molecule
Reverse transcriptase negative allosteric modulator
ORAL
Approved
HIV Infections; Virus Diseases
DORAVIRINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
913P6LK81M
Molecule Type:
Small molecule
Molecular Formula:
C17H11ClF3N5O3
Molecular Weight:
425.75
AlogP:
2.65
PSA:
105.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RIFAMYCIN
(2018)
Small molecule
Unknown
ORAL
Approved
Eye Infections; Tuberculosis
RIFAMYCIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
DU69T8ZZPA
Molecule Type:
Small molecule
Molecular Formula:
C37H47NO12
Molecular Weight:
697.78
AlogP:
4.75
PSA:
201.31
HBD:
6.0
HBA:
#RotB:
2.0
Source:
AMIFAMPRIDINE PHOSPHATE
(2018)
Small molecule
Voltage-gated potassium channel blocker
ORAL
Approved
Lambert-Eaton Myasthenic Syndrome
AMIFAMPRIDINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
8HF8FIN815
Molecule Type:
Small molecule
Molecular Formula:
C5H10N3O4P
Molecular Weight:
207.13
AlogP:
0.25
PSA:
64.93
HBD:
2.0
HBA:
#RotB:
0.0
Source:
DACOMITINIB
(2018)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
DACOMITINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
2XJX250C20
Molecule Type:
Small molecule
Molecular Formula:
C24H25ClFN5O2
Molecular Weight:
469.95
AlogP:
5.16
PSA:
79.38
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MIGALASTAT
(2018)
Small molecule
Alpha-galactosidase A stabiliser
Unknown
Approved
Unknown
MIGALASTAT
×
Maximum Phase:
4
First Approval:
2018
UNII:
C4XNY919FW
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO4
Molecular Weight:
163.17
AlogP:
-2.97
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
1.0
Source:
TAFENOQUINE SUCCINATE
(2018)
Small molecule
Unknown
ORAL
Approved
Malaria; Malaria, Vivax
TAFENOQUINE SUCCINATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
DL5J0B8VSS
Molecule Type:
Small molecule
Molecular Formula:
C28H34F3N3O7
Molecular Weight:
581.59
AlogP:
5.91
PSA:
78.63
HBD:
2.0
HBA:
#RotB:
9.0
Source:
PLAZOMICIN
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
PLAZOMICIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
LYO9XZ250J
Molecule Type:
Small molecule
Molecular Formula:
C25H48N6O10
Molecular Weight:
592.69
AlogP:
-5.36
PSA:
269.29
HBD:
11.0
HBA:
#RotB:
13.0
Source:
TAFENOQUINE
(2018)
Small molecule
Unknown
Unknown
Approved
Malaria
TAFENOQUINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
262P8GS9L9
Molecule Type:
Small molecule
Molecular Formula:
C24H28F3N3O3
Molecular Weight:
463.5
AlogP:
5.91
PSA:
78.63
HBD:
2.0
HBA:
#RotB:
9.0
Source:
STIRIPENTOL
(2018)
Small molecule
Unknown
ORAL
Approved
Epilepsies, Myoclonic; Epilepsy; Seizures
STIRIPENTOL
×
Maximum Phase:
4
First Approval:
2018
UNII:
R02XOT8V8I
Molecule Type:
Small molecule
Molecular Formula:
C14H18O3
Molecular Weight:
234.29
AlogP:
2.84
PSA:
38.69
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ERAVACYCLINE
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
ERAVACYCLINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
07896928ZC
Molecule Type:
Small molecule
Molecular Formula:
C27H31FN4O8
Molecular Weight:
558.56
AlogP:
0.29
PSA:
193.73
HBD:
6.0
HBA:
#RotB:
5.0
Source:
APALUTAMIDE
(2018)
Small molecule
Androgen Receptor antagonist
ORAL
Approved
Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
APALUTAMIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
4T36H88UA7
Molecule Type:
Small molecule
Molecular Formula:
C21H15F4N5O2S
Molecular Weight:
477.44
AlogP:
3.53
PSA:
89.33
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BARICITINIB
(2018)
Small molecule
Tyrosine-protein kinase JAK1 inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases
BARICITINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
ISP4442I3Y
Molecule Type:
Small molecule
Molecular Formula:
C16H17N7O2S
Molecular Weight:
371.43
AlogP:
1.1
PSA:
120.56
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
68
69
70
71
72
73
74
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA